| Basics |
|
Immunocore Holdings
|
| IPO Date: |
February 5, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.78B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.03 | 2.47%
|
| Avg Daily Range (30 D): |
$0.65 | 1.96%
|
| Avg Daily Range (90 D): |
$0.57 | 1.70%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.25M |
| Avg Daily Volume (30 D): |
.23M |
| Avg Daily Volume (90 D): |
.24M |
| Trade Size |
| Avg Trade Size (Sh.): |
73 |
| Avg Trade Size (Sh.) (30 D): |
70 |
| Avg Trade Size (Sh.) (90 D): |
69 |
| Institutional Trades |
| Total Inst.Trades: |
1,745 |
| Avg Inst. Trade: |
$1.8M |
| Avg Inst. Trade (30 D): |
$2.02M |
| Avg Inst. Trade (90 D): |
$1.56M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.6M |
| Avg Closing Trade (30 D): |
$2.05M |
| Avg Closing Trade (90 D): |
$1.66M |
| Avg Closing Volume: |
36.17K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.58
|
$
|
$-.2
|
|
Diluted EPS
|
$-.58
|
$
|
$-.2
|
|
Revenue
|
$ 379.59M
|
$ 103.69M
|
$ 97.96M
|
|
Gross Profit
|
$ 376.88M
|
$ 103.18M
|
$ 96.92M
|
|
Net Income / Loss
|
$ -29.23M
|
$ -.18M
|
$ -10.3M
|
|
Operating Income / Loss
|
$ -45.11M
|
$ -7.17M
|
$ -14.88M
|
|
Cost of Revenue
|
$ 2.71M
|
$ .51M
|
$ 1.04M
|
|
Net Cash Flow
|
$ -39.35M
|
$ 10.48M
|
$ 11.09M
|
|
PE Ratio
|
|
|
|
|
|
|